Literature DB >> 28933053

Incidence and all-cause mortality for hip fracture in comparison to stroke, and myocardial infarction: a fifteen years population-based longitudinal study.

Vincenzo Carnevale1, Andrea Fontana2, Alfredo Scillitani3, Roberto Sinisi4, Elisabetta Romagnoli5, Massimiliano Copetti2.   

Abstract

PURPOSE: This population-based study investigated the incidence, in-hospital and long-term all-cause mortality, for hip fracture (HipFx), stroke (STR), and myocardial infarction (MI) in residents hospitalized between 2000 and 2014.
METHODS: Data about hospitalization were drawn from the administrative discharge database, whereas information about residents and all-cause mortality from the municipality of our town. Patients were followed-up from the first hospital admission until death or study end. For each cause, crude and age-adjusted all-cause mortality of men and women were compared by Mann-Whitney's test and Poisson models. Separate age-sex adjusted Cox models were estimated and the corresponding adjusted survival curves were drawn.
RESULTS: Among 1292 hospitalizations (of 1109 patients), 434 were for HipFx, 526 for STR, 332 for MI (183 with and 149 without coronary revascularization -MIwCR and MIwoCR, respectively). The incidence of HipFx and STR did not vary over time, MI slightly increasing in men. Age-adjusted in-hospital mortality for HipFx was lower than for STR and MIwoCR in the whole sample and in women (p < 0.001), but not in men. After discharge, men with HipFx had shorter survival and higher crude and age-adjusted mortality rate than women. The estimated HRs(95%CI) in respect to patients with MIwCR (having the lowest mortality) were: 6.11(3.12-11.97), p < 0.001 for HipFx; 5.78(2.93-11.32), p < 0.001 for STR; 2.68(1.27-5.66), p = 0.010 for MIwoCR in the whole sample [HR: 16.58(6.70-40.98) p < 0.001 for HipFx; 7.35(3.01-17.93) p < 0.001 for STR, in men].
CONCLUSIONS: HipFx markedly impacts hospital care, and causes high in-hospital and long-term all-cause mortality, comparable to the two commonest non-tumor causes of death.

Entities:  

Keywords:  Hip fracture; Hospital admission; Mortality; Myocardial infarction; Stroke

Mesh:

Year:  2017        PMID: 28933053     DOI: 10.1007/s12020-017-1423-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  39 in total

1.  Increased risk of stroke in the year after a hip fracture: a population-based follow-up study.

Authors:  Jiunn-Horng Kang; Shiu-Dong Chung; Sudha Xirasagar; Fu-Shan Jaw; Herng-Ching Lin
Journal:  Stroke       Date:  2010-12-23       Impact factor: 7.914

2.  Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years.

Authors:  Raphael Carandang; Sudha Seshadri; Alexa Beiser; Margaret Kelly-Hayes; Carlos S Kase; William B Kannel; Philip A Wolf
Journal:  JAMA       Date:  2006-12-27       Impact factor: 56.272

3.  Changes in hip fracture incidence, mortality and length of stay over the last decade in an Australian major trauma centre.

Authors:  Nicole Williams; Ben M Hardy; Seth Tarrant; Natalie Enninghorst; John Attia; Christopher Oldmeadow; Zsolt J Balogh
Journal:  Arch Osteoporos       Date:  2013-09-19       Impact factor: 2.617

4.  Mortality after all major types of osteoporotic fracture in men and women: an observational study.

Authors:  J R Center; T V Nguyen; D Schneider; P N Sambrook; J A Eisman
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

5.  Meta-analysis: excess mortality after hip fracture among older women and men.

Authors:  Patrick Haentjens; Jay Magaziner; Cathleen S Colón-Emeric; Dirk Vanderschueren; Koen Milisen; Brigitte Velkeniers; Steven Boonen
Journal:  Ann Intern Med       Date:  2010-03-16       Impact factor: 25.391

6.  Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999-2011.

Authors:  Harlan M Krumholz; Sharon-Lise T Normand; Yun Wang
Journal:  Circulation       Date:  2014-08-18       Impact factor: 29.690

7.  The components of excess mortality after hip fracture.

Authors:  J A Kanis; A Oden; O Johnell; C De Laet; B Jonsson; A K Oglesby
Journal:  Bone       Date:  2003-05       Impact factor: 4.398

8.  Hip fracture and risk of acute myocardial infarction: a nationwide study.

Authors:  Chia-Hung Chiang; Chia-Jen Liu; Ping-Jen Chen; Chin-Chou Huang; Chien-Yi Hsu; Zu-Yin Chen; Wan-Leong Chan; Po-Hsun Huang; Tzeng-Ji Chen; Chia-Min Chung; Shing-Jong Lin; Jaw-Wen Chen; Hsin-Bang Leu
Journal:  J Bone Miner Res       Date:  2013-02       Impact factor: 6.741

9.  Increased risk of stroke among hip fracture patients: a nationwide cohort study.

Authors:  C-H Tsai; C-L Lin; H-C Hsu; W-S Chung
Journal:  Osteoporos Int       Date:  2014-10-10       Impact factor: 4.507

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  5 in total

1.  Hip Fractures in Older Adults in Ontario, Canada-Monthly Variation, Insights, and Implications.

Authors:  Kristin K Clemens; Alexandra Ouedraogo; Mark Speechley; Lucie Richard; Jenny Thain; Salimah Z Shariff
Journal:  Can Geriatr J       Date:  2019-09-30

2.  Impact of hip fracture on all-cause mortality in Japanese patients with type 2 diabetes mellitus: The Fukuoka Diabetes Registry.

Authors:  Yuji Komorita; Masanori Iwase; Yasuhiro Idewaki; Hiroki Fujii; Toshiaki Ohkuma; Hitoshi Ide; Tamaki Jodai-Kitamura; Masahito Yoshinari; Ai Murao-Kimura; Yutaro Oku; Udai Nakamura; Takanari Kitazono
Journal:  J Diabetes Investig       Date:  2019-06-12       Impact factor: 4.232

3.  Postoperative Pneumonia in Geriatric Patients With a Hip Fracture: Incidence, Risk Factors and a Predictive Nomogram.

Authors:  Xin Zhang; Zhi-Long Shen; Xu-Zhou Duan; Qi-Rong Zhou; Jie-Fu Fan; Jie Shen; Fang Ji; Da-Ke Tong
Journal:  Geriatr Orthop Surg Rehabil       Date:  2022-03-23

4.  Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy.

Authors:  Peter Malfertheiner; Claudio Ripellino; Nazarena Cataldo
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-19       Impact factor: 2.890

5.  Trends in Cardiometabolic and Cancer Multimorbidity Prevalence and Its Risk With All-Cause and Cause-Specific Mortality in U.S. Adults: Prospective Cohort Study.

Authors:  Liu Yang; Jiahong Sun; Min Zhao; Costan G Magnussen; Bo Xi
Journal:  Front Cardiovasc Med       Date:  2021-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.